GENAZZANI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 52.228
EU - Europa 20.115
AS - Asia 6.358
AF - Africa 84
OC - Oceania 47
SA - Sud America 37
Continente sconosciuto - Info sul continente non disponibili 28
Totale 78.897
Nazione #
US - Stati Uniti d'America 50.663
IT - Italia 6.312
CN - Cina 3.750
SE - Svezia 2.991
BG - Bulgaria 2.277
UA - Ucraina 2.126
PL - Polonia 1.792
CA - Canada 1.550
DE - Germania 1.238
TR - Turchia 884
CH - Svizzera 876
VN - Vietnam 844
FI - Finlandia 834
GB - Regno Unito 744
SG - Singapore 491
FR - Francia 305
RU - Federazione Russa 215
HK - Hong Kong 194
BE - Belgio 132
IN - India 95
CI - Costa d'Avorio 55
NL - Olanda 52
AU - Australia 34
IE - Irlanda 32
EU - Europa 28
RO - Romania 28
KR - Corea 25
BR - Brasile 24
ES - Italia 23
GR - Grecia 23
HU - Ungheria 18
CZ - Repubblica Ceca 16
DK - Danimarca 15
IL - Israele 15
PT - Portogallo 15
JP - Giappone 13
MX - Messico 13
NZ - Nuova Zelanda 13
HR - Croazia 9
AT - Austria 8
NG - Nigeria 8
CL - Cile 7
ID - Indonesia 7
PH - Filippine 7
EE - Estonia 6
NO - Norvegia 5
SN - Senegal 5
AL - Albania 4
EG - Egitto 4
IS - Islanda 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
AR - Argentina 3
BD - Bangladesh 3
CD - Congo 3
IR - Iran 3
MA - Marocco 3
RS - Serbia 3
SA - Arabia Saudita 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AF - Afghanistan, Repubblica islamica di 2
CY - Cipro 2
LK - Sri Lanka 2
LU - Lussemburgo 2
SC - Seychelles 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CO - Colombia 1
GH - Ghana 1
IM - Isola di Man 1
JM - Giamaica 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MC - Monaco 1
ME - Montenegro 1
MM - Myanmar 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
SD - Sudan 1
SI - Slovenia 1
VE - Venezuela 1
Totale 78.897
Città #
Woodbridge 8.160
Ann Arbor 5.939
Houston 5.452
Fairfield 5.347
Chandler 3.680
Milan 3.092
Jacksonville 2.853
Ashburn 2.677
Seattle 2.397
Sofia 2.276
Wilmington 2.026
Cambridge 1.868
Ottawa 1.495
New York 1.221
Beijing 1.127
Nanjing 900
Izmir 870
Bern 862
Princeton 849
Lawrence 841
Medford 806
Des Moines 630
Jüchen 504
Dearborn 497
Dong Ket 386
Nanchang 326
Singapore 256
San Diego 236
Falls Church 212
Kunming 191
Hong Kong 182
Rome 181
Shenyang 161
Boulder 160
Hebei 137
Marseille 135
Changsha 133
Brussels 130
Ogden 129
Tianjin 117
Lancaster 115
Norwalk 115
Hefei 104
Jiaxing 99
Redwood City 93
Orange 86
Frankfurt am Main 81
Verona 73
Los Angeles 70
Washington 70
Pune 65
Florence 63
Hangzhou 63
Düsseldorf 58
Abidjan 55
Serra 46
Jinan 43
London 43
Edinburgh 41
Lanzhou 39
Changchun 38
Indiana 38
Boardman 35
Guangzhou 35
Shanghai 32
Detroit 29
Zhengzhou 29
Ningbo 26
Toronto 25
Council Bluffs 23
San Francisco 23
Phoenix 22
Pisa 22
Dublin 21
Chicago 18
Chengdu 17
Tappahannock 17
Amsterdam 16
Auburn Hills 16
Seacroft 16
Taizhou 16
Dallas 14
Madrid 14
Boston 12
Stockholm 12
Budapest 11
Copenhagen 11
Delaware 11
Helsinki 11
Melbourne 11
Warsaw 11
Xian 11
Capannori 10
Sydney 10
Terni 10
Chehalis 9
Monmouth Junction 9
Montreal 9
Redmond 9
Walnut 9
Totale 61.581
Nome #
Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism 1.883
Menopause, Hormone Replacement Therapy (HRT) and Obesity 299
Plasma and CSF endorphin levels in primary and symptomatic headaches. 181
Clinical and endocrinological investigations on superovulation induced in heifers by human menopausal gonadotrophin. 174
Optimizing quality of life through sex steroids by their effects on neurotransmitters 169
Secretion pattern of endogenous opioids in chronic schizophrenia. 159
Plasma androgens and menstrual cycle: physiopathological correlates from adolescence to menopause. 158
The relative contributions of menopause and aging to postmenopausal reduction in intervertebral disk height 157
Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. 154
The HRT misuse and osteoporosis epidemic: a possible future scenario 154
Opioids and testicular activity in the frog, Rana esculenta. 153
Pituitary response to hypoglycemia in pituitary diseases. 152
Cytogenetic study on 282 patients with suspected chromosomal aberration. 150
Endogenous opioid inhibitory tone on LH secretion in normal puberty and in several pubertal disturbances. 150
Domperidone in defective and insufficient lactation. 149
Absent B-endorphin response to clonidine in obese children. 149
Estimation of instantaneous secretory rate of luteinizing hormone in women during the menstrual cycle and in men. 148
Plasma thyrotrophin levels during pregnancy. 147
Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensine. 147
The association of menstrual migraine with the premenstrual syndrome. 147
Plasma opioid levels in post-traumatic chronic headache and trigeminal neuralgia: maintained response to acupuncture. 146
Oestradiol/progesterone imbalance and the premenstrual syndrome. 146
Opioid peptides of the pituitary and hypothalamus: changes in pregnant and lactating rats. 145
Doppler ultrasound studies of the uterine arteries in spontaneous and IVF stimulated ovarian cycles. 145
Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. 145
Endothelium and estrogen receptors 145
Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells 145
Lack of beta-endorphin plasma level rise in oxytocin-induced labor. 144
Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women 144
Plasma levels of gonadotropins, prolactin, thyroxine, and adrenal and gonadal steroids in obese prepubertal girls. 143
Factors associated with pain complaints in a clinical sample of postmenopausal women. 143
Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. 143
Presence of acetylated and shortened endorphins in human fetal pituitary gland. 142
Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy Villa Tuscolana, Frascati (Rome), May 8-9, 2007 142
Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists. 141
Circulating opioids and plasma renin activity in insulin-dependent diabetics with renal haemodynamic alterations. 141
Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor 141
Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology. 140
Adrenal and gonadal steroids in girls during sexual maturation. 140
Dermorphin decreases plasma LH levels in human: evidence for a modulatory role of gonadal steroids. 140
Pregnancy diagnosis in cattle by a rapid and highly reliable method for progesterone determination in milk. 140
The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy 140
Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome 140
Nomifensine: diagnostic test in hyperprolactinemic states. 139
Response of circulating adrenocorticotropin, beta-endorphin, beta-lipotropin and cortisol to athletic competition. 139
Opioid control of luteinizing hormone secretion in patients with hirsutism and hyperandrogenemia. 139
Reduced cerebrospinal fluid B-endorphin levels in Rett syndrome. 139
Dydrogesterone increases allopregnanolone in selected brain areas and in serum of female rats 139
Adrenal and gonadal steroids and pituitary response to LHRH in girls. II. Precocious puberty. 138
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome 138
Concomitant increase in nociceptive flexion reflex threshold and plasma opioids following transcutaneous nerve stimulation. 137
Progressive impairment of CSF beta-EP levels in migraine sufferers. 137
Expression of proopiomelanocortin-related peptides in human follicular fluid. 137
Pituitary proopiomelanocortin peptides in mental disorders. 137
Menstrual-related mood changes in patients with oligomenorrhea. 137
Different rebound rise in plasma prolactin during the postdopamine infusion phase in puerperal women and patients with pathological hyperprolactinemia 136
Endorphin patterns within the headache spectrum disorders. 136
Central opioid receptor activity in patients affected by puerperal, idiopathic and tumoral hyperprolactinemia. 136
Pregnancy related changes of opiate receptors identified in rat uterine membranes by 3H-naloxone binding. 136
Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women. 136
Glucocorticoids but not vasopressin or oxytocin inhibit luteinizing hormone secretion in patients with psychogenic amenorrhea. 136
Human neu oncogene is expressed in endometrial but not in ovarian adenocarcinomas. 136
Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy. 136
Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency 136
Nomifensine-induced pregnancy in a hyperprolactinemic woman. 135
Plasma opioids in the first hours of life. 135
Proopiomelanocortin-related peptides and methionine enkephalin in human follicular fluid: changes during the menstrual cycle. 135
Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels. 135
Plasma beta-endorphin and beta-lipotropin levels increase in well trained athletes after competition and non competitive exercise. 135
Opioid plasma levels during labour. 134
Intrinsic secretory characteristics of luteinizing hormone and prolactin episodic release during pubertal development. 134
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women 134
Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study. 133
Episodic release of prolactin in women with weight loss-related amenorrhea. 133
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists. 133
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea. 133
From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health 133
Pharmacotherapy: Benefits of menopausal hormone therapy--timing is key. 133
Circulating beta-endorphin levels at various stages of life: possible connections with migraine pathogenesis. 132
Hypothalamus-pituitary-adrenal axis of heroin addicts. 132
Plasma levels of luteinizing hormone, estradiol and androstenedione in sows with inadequate plasma progesterone. 132
Fetal intermediate lobe is stimulated by parturition 132
Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. 132
Abnormal concentration of maternal serum activin-A in gestational diseases. 132
Contraception in older woman. 132
Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women. 132
Use of human-placental-lactogen radioimmunoassay to predict outcome in cases of threatened abortion. 131
Impairment of adrenergic-induced proopiomelanocortin-related peptide release in heroin addicts. 131
Impairment of opioid control of luteinizing hormone secretion in menstrual disorders. 131
Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis 131
Opioid control of luteinizing hormone secretion in humans. 130
Abnormal beta-endorphin and beta-lipotropin responses to TRH and LRH administration in primary and secondary affective disorders. 130
The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors. 130
Pulsed estrogen exposure selectively modulates tissue response: a hypothesis 130
Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women 130
Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm 130
Adrenal and gonadal steroids and pituitary response to LHRH in girls. I. Delayed puberty. 129
Placental impermeability to maternal ACTH in the rabbit. 129
Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia. 129
Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea 129
Totale 15.892
Categoria #
all - tutte 171.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 171.159


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.861 0 0 0 0 0 0 0 0 0 0 0 1.861
2019/202014.566 1.798 1.340 300 1.029 1.763 1.582 1.797 1.143 1.665 749 1.156 244
2020/20217.218 821 288 740 365 884 245 566 694 467 638 405 1.105
2021/20228.772 72 341 137 741 1.943 1.361 180 386 623 226 304 2.458
2022/20238.366 1.193 702 344 799 1.231 1.315 100 761 1.247 46 527 101
2023/202410.973 1.944 1.174 1.512 628 1.315 1.403 106 300 176 1.867 85 463
Totale 79.350